Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

herbal viagra

Popular Articles

Grant more for allied sectors of agriculture: House panel
Recommending higher allocation for animal husbandry, dairy and fisheries, a House panel has wondered as to why the sector got only 7.7 per cent of the allocated funds of the Agriculture Ministry last fiscal, even though it accounted for 31 per cent of the total farm output. generic levitra

payday loans online
SC restrains UP govt from action against Kotak Mahindra Bank
The Supreme Court has restrained the Uttar Pradesh government and others from initiating recovery proceedings against Kotak Mahindra Bank in a matter related to trading of debts by banks.

News of the day

Punj Lloyd to bid for 25 highways next year
Infrastructure major Punj Lloyd today said it will bid for up to 25 national highway projects, valued at an estimated Rs 40,000 crore, in the next one year.
Online Business

Ranbaxy to sell Neronox in India

Ranbaxy Laboratories has entered into a licensing agreement with South Korean firm Medy-Tox Inc for selling its cosmetic product, Neuronox, in India. - Orchid gets USFDA nod for injection, gets 6-mth exclusivity - Glenmark raises Rs 413 cr through QIP - Suven Life gets two more US patents for NCEs - SC issues notices to Centre, others on Novartis petition - Road to recovery: Gujarat"s pharma share rises to 30% - Aurobindo Pharma receives Swissmedic approval The company in a statement to the Bombay Stock Exchange said, it will launch Medy-Tox"s anti-ageing medicine Neuronox in India to boost its presence in the dermatological segment. Commenting on the development Sanjeev Dani, Sr Vice President and Regional Director, Ranbaxy, said, “Neuronox comes as a welcome alternative to dermatologists in India and we aim to make botulinum toxin therapy more accessible and affordable to people in the country.” Ranbaxy scrip was trading at Rs 358, up 0.83 per cent on the Bombay Stock Exchange.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009